2018 POSTER PRESENTATIONS
Room: White Plains Ballroom
Presenting Wednesday-Friday
Poster Presenters noted with * are Student Fellows.
Agency for Science, Technology and Research (A*STAR)
1. DAPPLeD: Data Analytics Platform for Phenotypic Lead Discovery; Presented by Judice K.
AstraZeneca
2. Liver Spheroids as a Model to Determine Hepatic Safety and Metabolism; Presented by Linda A.
AstraZeneca
3. Evaluation and Characterization of Human Hepatocyte Donors to Be Used for ADME and Safety in Liver Spheroid Model; Presented by Bhavik C.
Biogelx Ltd.
4. Designer Hydrogels for 3D Cell Culture and Bioprinting; Presented by Elia L.
Biotrial
5. Mouse Models of Nonalcoholic Steatohepatitis (NASH) and NASH-Derived Hepatocellular Carcinoma in Preclinical Drug Development; Presented by Pierre M.
CILcare
6. The Antioxidant N-Acetyl-L-Cysteine (NAC) as a Pharmacological Candidate for Age-Related Hearing Loss; Presented by Sylvie C.
Crown Bioscience, Inc.
7. Generation of Human Immune Checkpoint Double Knock-In Mice (dKI HuGEMM) for Preclinical Efficacy Assessment of Combinatorial Therapeutic Antibodies; Presented by Sebastian D.
Cyprotex Discovery
8. A Comprehensive Approach Using In Vitro Assays to Detect and Identify Mechanism of Mitochondrial Toxicity; Presented by Julie E.
genOway
9. Anti-Tumor Efficacy of Anti-GITR in Preclinical hGITR Model; Presented by Kader T.
Gilead Sciences
10. SEND Systems Approach; Presented by Nidhi N.
Glycotope GmbH
11. A Highly Tumor-Specific T Cell Engaging Bispecific Antibody Targeting TA-MUC1 Induces Strong T Cell Infiltration in 3D MCF-7 Tumor Spheroids; Presented by Timo L.
Hungarian Academy of Sciences
12. Functional Characterization of Human Neural Progenitor Cells Differentiated from Pluripotent Stem Cells; Presented by Agota A.
Hybrigenics Services SAS
13. Phenotypic Screening Combined to Target Deconvolution Identifies Novel Modulators of Beta-Cell Regeneration; Presented by Marie-Edith G.
Jesus Uson Minimally Invasive Surgery Centre (JUMISC)
14. Feasibility Study Combined with Diagnostic Techniques of Colorectal Cancer Such as Endoscopy, Solid Biopsies and Liquid Biopsies in a Murine Model; Presented by Jorge B.*
Jesus Uson Minimally Invasive Surgery Centre (JUMISC)
15. Pre-Clinical Stage to Develop a Multimodal Highly-Sensitive Photonics Endoscope for Improved In-Vivo Colon Cancer Diagnosis and Clinical Decision Support; Presented by Jose G.*
Ludwig-Maximilians-University of Munich
16. Pathway Sensor-Based Functional Genomics Screening Identifies Modulators of Neuronal Activity; Presented by Alexander H.
Mahidol University
17. Development of Interpretable Computational Models for Breast Cancer Drug Discovery; Presented by Naravut S.*
MicroMatrices Associates Ltd.
18. An iPSC Platform for Brain Tumour Drug Development and Personalised Medicine; Presented by Simon P.
MI-mAbs (Protisvalor)
19. CD3ε Humanized Mice: A New Tool to Validate Your Bi-Specific T Cell Engager Molecule; Presented by Agnes M.
Ncardia
20. Simultaneous Measurement of Contractility, Electrophysiology, and Troponin I Secretion to Determine Cardiotoxicity in hiPSC-Derived Cardiomyocytes; Presented by Alexandre F.
NEBION AG
21. Transcriptomics Data Integration: Promoting Target Discovery in Immuno-Oncology; Presented by Natalie R.
Oxford NanoImaging Ltd.
22. The Power of Single-Molecule Fluorescent Techniques in the Development of Improved Drug Discovery and Target Validation Platforms; Presented by Mariya G.
ProQinase GmbH
23. New Spontaneous and Carcinogen Induced Mouse Derived Isograft (MDI) Tumor Models for Drug Development of Novel Immune Therapeutic Approaches; Presented by Bettina S.
TNO - The Netherlands Organization for Applied Scientific Research
24. Organ Cross-Talk in the Development of Obesity-Related Diseases; Presented by Ivana B.
TNO - The Netherlands Organization for Applied Scientific Research
25. Development of a Diet-Induced Disease-Mimicking In Vitro Model of Non-Alcoholic Steatohepatitis (NASH)/ Fibrosis; Presented by Elsbet P.
TNO - The Netherlands Organization for Applied Scientific Research
26. GUT ON-A-CHIP: Intestinal Barrier Model for Studying Host Microbe-Immune Responses; Presented by Evita V.
TNO - The Netherlands Organization for Applied Scientific Research
27. Novel Translational Approaches for Preclinical Research in the Area of Non-Alcoholic Fatty Liver Disease; Presented by Lars V.
University of Illinois at Chicago
28. Target Discovery of Natural Product Inspired Phyllanthusmins for Treatment of High Grade Serous Ovarian Cancer; Presented by Alexandria Y.*
University of Lisbon
29. Ablation of TREM-2 Reveals a Resident Macrophage Population Impairing Tissue Repair Responses to Liver Damage; Presented by Ines C.*
Tempo Bioscience, Inc.
30. Human iPSC Models for Drug Discovery; Presented by Angela H.
São Paulo State University - UNESP
31. GA-Hecate Antiviral Properties on HCV Whole Cycle Represent a New Antiviral Class and Open the Door for the Development of Broad Spectrum Antivirals; Presented by Paulo S.*